MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
Public ClinicalTrials.gov record NCT05409989. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT05409989
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Microvention-Terumo, Inc.
- Industry
- Enrollment
- 154 participants
Conditions and interventions
Conditions
Interventions
- FRED™ X™ Device
Device
Eligibility (public fields only)
- Age range
- 22 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 19, 2022
- Primary completion
- Mar 31, 2026
- Completion
- Apr 30, 2030
- Last update posted
- Mar 23, 2026
2022 – 2030
United States locations
- U.S. sites
- 23
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Memorial Healthcare Systems | Hollywood | Florida | 33021 | — |
| Orlando Health | Orlando | Florida | 32806 | — |
| Queen's Medical Center | Honolulu | Hawaii | 96813 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| University of Kansas | Kansas City | Kansas | 66160 | — |
| Baptist Healthcare System | Louisville | Kentucky | 40207 | — |
| Norton Healthcare | Louisville | Kentucky | 40241 | — |
| Ochsner Health | New Orleans | Louisiana | 70121 | — |
| The Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| Massachusetts General Brigham Incorporated | Boston | Massachusetts | 02114 | — |
| UMass Memorial Health | Worcester | Massachusetts | 01655 | — |
| Albany Medical Center | Albany | New York | 12208 | — |
| University at Buffalo | Buffalo | New York | 14203 | — |
| Northwell Health | Manhasset | New York | 11030 | — |
| Mount Sinai | New York | New York | 10029 | — |
| Stony Brook University | Stony Brook | New York | 11794 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| ProMedica Toledo Hospital | Toledo | Ohio | 43606 | — |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Houston Methodist Hospital | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05409989, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 23, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05409989 live on ClinicalTrials.gov.